T1	Participants 112 126	ovarian cancer
T2	Participants 350 378	Patients with stage IC-IV OC
T3	Participants 1097 1109	919 patients
T4	Participants 1120 1140	352 patients with CR
T5	Participants 601 637	Patients with complete response (CR)
T6	Participants 733 752	Patients without CR
T7	Participants 1183 1206	155 patients without CR
